315 related articles for article (PubMed ID: 15655784)
1. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
[TBL] [Abstract][Full Text] [Related]
2. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
[TBL] [Abstract][Full Text] [Related]
3. The Decoy Receptor 3 (DcR3, TNFRSF6B) suppresses Th17 immune responses and is abundant in human cerebrospinal fluid.
Mueller AM; Pedré X; Killian S; David M; Steinbrecher A
J Neuroimmunol; 2009 Apr; 209(1-2):57-64. PubMed ID: 19269042
[TBL] [Abstract][Full Text] [Related]
4. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria.
Matute-Bello G; Frevert CW; Liles WC; Nakamura M; Ruzinski JT; Ballman K; Wong VA; Vathanaprida C; Martin TR
Infect Immun; 2001 Sep; 69(9):5768-76. PubMed ID: 11500454
[TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor.
Connolly K; Cho YH; Duan R; Fikes J; Gregorio T; LaFleur DW; Okoye Z; Salcedo TW; Santiago G; Ullrich S; Wei P; Windle K; Wong E; Yao XT; Zhang YQ; Zheng G; Moore PA
J Pharmacol Exp Ther; 2001 Jul; 298(1):25-33. PubMed ID: 11408521
[TBL] [Abstract][Full Text] [Related]
6. Early production of tumor necrosis factor-alpha by Gr-1 cells and its role in the host defense to pneumococcal infection in lungs.
Hatta M; Yamamoto N; Miyazato A; Ishii N; Nakamura K; Inden K; Aoyagi T; Kunishima H; Hirakata Y; Suzuki K; Kaku M; Kawakami K
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):182-92. PubMed ID: 19909342
[TBL] [Abstract][Full Text] [Related]
7. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia.
Dallaire F; Ouellet N; Bergeron Y; Turmel V; Gauthier MC; Simard M; Bergeron MG
J Infect Dis; 2001 Aug; 184(3):292-300. PubMed ID: 11443554
[TBL] [Abstract][Full Text] [Related]
8. Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony-stimulating factor in murine pneumococcal pneumonia.
Knapp S; Hareng L; Rijneveld AW; Bresser P; van der Zee JS; Florquin S; Hartung T; van der Poll T
J Infect Dis; 2004 Apr; 189(8):1506-15. PubMed ID: 15073689
[TBL] [Abstract][Full Text] [Related]
9. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae.
Kerr AR; Wei XQ; Andrew PW; Mitchell TJ
Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
12. Role of endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation.
Matter CM; Chadjichristos CE; Meier P; von Lukowicz T; Lohmann C; Schuler PK; Zhang D; Odermatt B; Hofmann E; Brunner T; Kwak BR; Lüscher TF
Circulation; 2006 Apr; 113(15):1879-87. PubMed ID: 16606788
[TBL] [Abstract][Full Text] [Related]
13. Enterocyte apoptosis after enterectomy in mice is activated independent of the extrinsic death receptor pathway.
Knott AW; O'Brien DP; Juno RJ; Zhang Y; Williams JL; Erwin CR; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G404-13. PubMed ID: 12724132
[TBL] [Abstract][Full Text] [Related]
14. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
15. The Fas/Fas-ligand pathway does not mediate the apoptosis in elastase-induced emphysema in mice.
Sawada M; Ohno Y; La BL; Funaguchi N; Asai T; Yuhgetsu H; Takemura G; Minatoguchi S; Fujiwara H; Fujiwara T
Exp Lung Res; 2007 Aug; 33(6):277-88. PubMed ID: 17694438
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system.
Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL
Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012
[TBL] [Abstract][Full Text] [Related]
17. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen.
Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H
Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484
[TBL] [Abstract][Full Text] [Related]
18. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue.
Wortinger MA; Foley JW; Larocque P; Witcher DR; Lahn M; Jakubowski JA; Glasebrook A; Song HY
Immunology; 2003 Oct; 110(2):225-33. PubMed ID: 14511236
[TBL] [Abstract][Full Text] [Related]
19. Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.
Rijneveld AW; Weijer S; Florquin S; Speelman P; Shimizu T; Ishii S; van der Poll T
J Infect Dis; 2004 Feb; 189(4):711-6. PubMed ID: 14767826
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis.
Engelbert M; Gilmore MS
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2479-86. PubMed ID: 15980239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
